Freedom Broker raises Biogen stock price target on strong results
Covered in this story
What has happened since
- Biogen is up 1.5% since this was published, 16 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Bank of America’s $257 target on $BIIB is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Bank of America’s track record →Tracked from this story
Freedom Broker’s $275 target on $BIIB is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Freedom Broker’s track record →Tracked from this story
Baird’s $290 target on $BIIB is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Baird’s track record →Analyst targets on Biogen
- BMO Capital Markets: at $229 · target $220 by Oct 2027 · Market Perform via Investing.com
- Wolfe Research: at $216 · target $300 by Sep 2027 · Outperform via Yahoo Finance
- H.C. Wainwright: at $203 · target $251 by Jul 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BIIB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Biogen →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.